A Randomized Study of Interferon α‐2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma

Cell Transplantation ◽

Randomized Study ◽

Interferon Α ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Relapsed Lymphoma

Faculty of 1000 evaluation for A Randomized Study of Interferon α-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718136957.793486440 ◽

2013 ◽

Author(s):

Nicolas Mounier

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Randomized Study ◽

Interferon Α ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Relapsed Lymphoma

Faculty Opinions recommendation of Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047696.497693 ◽

2006 ◽

Author(s):

Ginna Laport

Keyword(s):

Stem Cell ◽

Follicular Lymphoma ◽

Cell Transplantation ◽

Randomized Study ◽

High Dose ◽

High Dose Therapy ◽

Standard Chemotherapy ◽

REDUCED SEXUAL FUNCTION IN LONG-TERM MALE LYMPHOMA SURVIVORS AFTER HIGH DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION

Hematological Oncology ◽

10.1002/hon.231_2631 ◽

2019 ◽

Vol 37 ◽

pp. 544-545

Author(s):

H.S. Bersvendsen ◽

H.S. Haugnes ◽

U. Fagerli ◽

Ø. Fluge ◽

H. Holte ◽

...

Keyword(s):

Stem Cell ◽

Sexual Function ◽

Cell Transplantation ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Lymphoma Survivors

Phase 2 randomized study of daratumumab (dara), lenalidomide (R), bortezomib (V), and dexamethasone (d; Dara-RVd) vs. RVd in patients (pts) with newly diagnosed multiple myeloma (MM) eligible for high-dose therapy (HDT) and autologous stem cell transplantation (ASCT)

Annals of Oncology ◽

10.1093/annonc/mdx373.044 ◽

2017 ◽

Vol 28 ◽

pp. v369

Author(s):

T. Lin ◽

L. Hydutsky ◽

H. Parros ◽

S. Murphy ◽

H. Pei ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Randomized Study ◽

High Dose ◽

Phase 2 ◽

Newly Diagnosed ◽

High Dose Therapy

High-dose Therapy Supported by Autologous Stem Cell Transplantation in Patients with Enteropathy-associated T-cell Lymphoma

Leukemia & Lymphoma ◽

10.1080/1042819031000123456 ◽

2003 ◽

Vol 44 (12) ◽

pp. 2163-2164 ◽

Cited By ~ 24

Author(s):

E. Jantunen ◽

E. Juvonen ◽

T. Wiklund ◽

M. Putkonen ◽

T. Nousiainen

Keyword(s):

Stem Cell ◽

T Cell ◽

Cell Transplantation ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

High Dose ◽

High Dose Therapy ◽

Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1700838 ◽

1997 ◽

Vol 20 (1) ◽

pp. 21-26 ◽

Cited By ~ 113

Author(s):

P Brice ◽

◽

R Bouabdallah ◽

P Moreau ◽

M Divine ◽

...

Keyword(s):

Stem Cell ◽

Prognostic Factors ◽

Cell Transplantation ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

French Registry ◽

Disease Analysis

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

Acta Haematologica ◽

10.1159/000074220 ◽

2003 ◽

Vol 110 (4) ◽

pp. 173-178 ◽

Cited By ~ 5

Author(s):

Muzaffar H. Qazilbash ◽

Marcel P. Devetten ◽

Jame Abraham ◽

Joseph P. Lynch ◽

Charles L. Beall ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Prognostic Model ◽

Hodgkin’S Disease ◽

Disease Outcome ◽

High Dose ◽

High Dose Therapy ◽

Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma

Leukemia & Lymphoma ◽

10.3109/10428194.2011.624227 ◽

2012 ◽

Vol 53 (4) ◽

pp. 596-602 ◽

Cited By ~ 4

Author(s):

Mona Shafey ◽

Qiuli Duan ◽

James Russell ◽

Peter Duggan ◽

Alex Balogh ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

High Dose Melphalan ◽

Refractory Hodgkin Lymphoma

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1705178 ◽

2005 ◽

Vol 36 (11) ◽

pp. 955-961 ◽

Cited By ~ 25

Author(s):

C Andreadis ◽

S J Schuster ◽

E A Chong ◽

J Svoboda ◽

S M Luger ◽

...

Keyword(s):

Stem Cell ◽

Follicular Lymphoma ◽

Cell Transplantation ◽

High Dose ◽

Low Grade ◽

High Dose Therapy ◽

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

Cancer ◽

10.1002/cncr.21313 ◽

2005 ◽

Vol 104 (7) ◽

pp. 1434-1441 ◽

Cited By ~ 32

Author(s):

Catherine Thieblemont ◽

Daciana Antal ◽

Laurence Lacotte-Thierry ◽

Vincent Delwail ◽

Daniel Espinouse ◽

...

Keyword(s):

Stem Cell ◽

Mantle Cell Lymphoma ◽

Cell Transplantation ◽

Cell Lymphoma ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Mantle Cell